Evolus Stock (NASDAQ: EOLS) stock price, news, charts, stock research, profile.
Open | $12.34 |
Close | $12.31 |
Volume / Avg. | 250.43K / 540.60K |
Day Range | 12.05 - 12.40 |
52 Wk Range | 7.11 - 15.43 |
Market Cap | $770.74M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 59 |
Short Interest | 8.57% |
Days to Cover | 14.92 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Evolus (NASDAQ:EOLS) through any online brokerage.
Other companies in Evolus’s space includes: Theravance Biopharma (NASDAQ:TBPH), Third Harmonic Bio (NASDAQ:THRD), GH Research (NASDAQ:GHRS), SNDL (NASDAQ:SNDL) and WAVE Life Sciences (NASDAQ:WVE).
There is no analysis for Evolus.
Evolus has a consensus price target of $20.50.
The stock price for Evolus (NASDAQ: EOLS) is $12.31 last updated July 26, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Evolus.
Evolus’s Q2 earnings are confirmed for Wednesday, July 31, 2024.
There is no upcoming split for Evolus.
Evolus is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.